Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Dr. Reddy's Laboratories Ltd (RDY)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart

Fundamentals

See More
  • Market Capitalization, $K 6,044,667
  • Shares Outstanding, K 165,880
  • Annual Sales, $ 2,171 M
  • Annual Income, $ 186,000 K
  • 36-Month Beta 0.36
  • Price/Sales 2.79
  • Price/Cash Flow 16.77
  • Price/Book 3.16

Price Performance

See More
Period Period Low Period High Performance
1-Month
33.99 +6.83%
on 09/27/17
38.27 -5.12%
on 09/21/17
+1.75 (+5.06%)
since 09/19/17
3-Month
29.83 +21.72%
on 08/21/17
42.60 -14.77%
on 07/21/17
-6.20 (-14.58%)
since 07/19/17
52-Week
29.83 +21.72%
on 08/21/17
50.10 -27.52%
on 11/01/16
-9.79 (-21.24%)
since 10/19/16

Most Recent Stories

More News
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Dr. Reddy's Laboratories Ltd. - RDY

NEW YORK, NY / ACCESSWIRE / October 19, 2017 / Pomerantz LLP is investigating claims on behalf of investors of Dr. Reddy's Laboratories Ltd. ("Dr. Reddy's" or the "Company") (NYSE: RDY). Such investors...

RDY : 36.31 (-0.36%)
RDY SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Dr. Reddy's Laboratories Ltd. and a Lead Plaintiff Deadline of October 24, 2017

NEW YORK, NY / ACCESSWIRE / October 19, 2017 / The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the United States District Court for the District of New Jersey...

RDY : 36.31 (-0.36%)
5-DAY DEADLINE: Khang & Khang LLP Announces Securities Class Action Lawsuit against Dr. Reddy's Laboratories Limited and Reminds Investors with Losses to Contact the Firm

IRVINE, CA / ACCESSWIRE / October 19, 2017 / Khang & Khang LLP (the "Firm") announces a securities class action lawsuit against Dr. Reddy's Laboratories Limited ("Dr. Reddy's" or the "Company") (NYSE:...

RDY : 36.31 (-0.36%)
Scott+Scott, Attorneys at Law, LLP Reminds Investors of October 24th Lead Plaintiff Deadline in Securities Class Action Against Dr. Reddy's Laboratories Limited (RDY)

Scott+Scott, Attorneys at Law, LLP ("Scott+Scott"), a national shareholder and consumer rights litigation firm, reminds investors that October 24th is the deadline for lead plaintiff...

RDY : 36.31 (-0.36%)
DR. REDDY'S INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 in Dr. Reddy's Laboratories Limited to Contact the Firm

Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Dr. Reddy's Laboratories Limited ("Dr. Reddy's" or the "Company") (NYSE:RDY) of the October 24, 2017 deadline...

RDY : 36.31 (-0.36%)
EQUITY ALERT: Goldberg Law PC Announces a Securities Class Action Lawsuit against Dr. Reddy's Laboratories Limited

Goldberg Law PC, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Dr. Reddy's Laboratories Limited ("Dr. Reddy's" or the "Company") (NYSE: RDY) for...

RDY : 36.31 (-0.36%)
Glancy Prongay & Murray Reminds Investors of the October 24th Deadline in the Class Action Lawsuit Against Dr. Reddy's Laboratories, Ltd. (RDY)

Glancy Prongay & Murray LLP ("GPM") reminds investors of the October 24, 2017 deadline to file a lead plaintiff motion in the class action filed on behalf of investors that purchased...

RDY : 36.31 (-0.36%)
EQUITY ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Dr. Reddy's Laboratories Ltd. of a Class Action Lawsuit and a Lead Plaintiff Deadline of October 24, 2017 - RDY

NEW YORK, NY / ACCESSWIRE / October 18, 2017 / The following statement is being issued by Levi & Korsinsky, LLP:

RDY : 36.31 (-0.36%)
DEADLINE REMINDER: Lundin Law PC Announces Securities Class Action Lawsuit against Dr. Reddy's Laboratories Limited and Encourages Investors with Losses to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / October 18, 2017 / Lundin Law PC, a shareholder rights firm, announces a class action lawsuit against Dr. Reddy's Laboratories Limited ("Dr. Reddy's" or the "Company") (NYSE:...

RDY : 36.31 (-0.36%)
ONE WEEK DEADLINE: Khang & Khang LLP Announces Securities Class Action Lawsuit against Dr. Reddy's Laboratories Limited and Reminds Investors with Losses to Contact the Firm

IRVINE, CA / ACCESSWIRE / October 17, 2017 / Khang & Khang LLP (the "Firm") announces a securities class action lawsuit against Dr. Reddy's Laboratories Limited ("Dr. Reddy's" or the "Company") (NYSE:...

RDY : 36.31 (-0.36%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Buy with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum.

See More

Business Summary

Doctor Reddy's is an emerging global pharmaceutical company with proven research capabilities. They are vertically integrated with a presence across the pharmaceutical value chain. They produce finished dosage forms, active pharmaceutical ingredients and biotechnology products and market them globally,...

See More

Support & Resistance

2nd Resistance Point 36.70
1st Resistance Point 36.51
Last Price 36.31
1st Support Level 36.10
2nd Support Level 35.88

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart